ArticleInternational medical case reports journal2026
Exudative Retinal Detachment During Induction Therapy for Acute Promyelocytic Leukemia: A Manifestation of Differentiation Syndrome.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: This report describes a case of exudative retinal detachment as an ocular manifestation of differentiation syndrome (DS) during induction therapy for acute promyelocytic leukemia (APL). A concise review of the literatures is also provided. Case Presentation: A 25-year-old female with APL received induction therapy with all-trans retinoic acid (ATRA), arsenic trioxide (ATO), and daunorubicin. On day 15 of induction therapy, she developed dyspnea with pulmonary infiltrates, alongside bilateral epiphora and blurred vision in her right eye. Ophthalmic examination revealed a best-corrected visual acuity (BCVA) of 20/40 in the right eye and 20/20 in the left. Fundus examination demonstrated macular edema, mild optic disc edema, undulating exudative retinal detachment in the posterior pole and mid-peripheral retina, and scattered superficial hemorrhages bilaterally. Optical coherence tomography demonstrated corrugated retinal pigment epithelium elevation with subretinal fluid (SRF), choroidal thickening in both eyes, and neurosensory epithelium detachment in the right macula. Fundus fluorescein angiography confirmed diffuse vascular leakage bilaterally. A diagnosis of DS was established. Management with systemic corticosteroids, ATRA dose reduction, and ATO discontinuation led to the complete resolution of SRF and restoration of BCVA to 20/20 in both eyes within one month. Conclusion: Exudative retinal detachment can be an ocular manifestation of DS during APL induction therapy, likely attributable to systemic capillary leakage. Prompt intervention with systemic corticosteroids is effective and generally associated with a favorable visual prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.